(HealthDay)—There are high rates of macrolide-resistant Streptococcus pneumoniae throughout the United States, according to a study published online Feb. 4 in Open Forum Infectious Diseases. Vikas Gupta, Pharm.D., from Becton, Dickinson and Company (BD) in Franklin Lakes, New Jersey, and colleagues used the BD Insights Research Database to identify 3,626 patients with a positive S.